- call +1-201-465-4211
- email sales@mrinsights.biz
Bacterial vaccines contain killed or attenuated bacteria that activate the immune system. Different types of bacterial vaccines include, capsular polysaccharide vaccines, toxoid vaccines, purified protein vaccines, live attenuated bacterial vaccines, and killed bacterial vaccines.
Scope of the Report:
Rise in prevalence of several infectious and non-infectious diseases and technological advancements are projected to drive the global bacterial vaccines market during the forecast period. Additionally, increase in vaccination programs, government and non-government initiatives, and rise in demand for combination vaccines boost the growth of the global market.
North America is projected to account for the largest share of the global market from 2018 to 2025, due to increase in initiatives by the United States Department of Health and Human Services (HHS). Europe is expected to be the second largest market for bacterial vaccines during the forecast period, due to rise in prevalence of infectious diseases, government initiatives, and focused product development. The bacterial vaccines market in Asia Pacific is expected to grow at a rapid pace during the forecast period. Growth of the market in the region is attributed to increase in awareness about prevention of bacterial diseases, rapidly developing health care infrastructure, and rise in adoption of technology in the region.
The global Bacterial Vaccines market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Bacterial Vaccines.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Bacterial Vaccines market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Bacterial Vaccines market by product type and applications/end industries.
Market Segment by Companies, this report covers
Pfizer
Merck
GlaxoSmithKline
Sanofi
PaxVax
Serum Institute of India
Emergent BioDefense Operations Lansing
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Capsular Polysaccharide Vaccines
Toxoid Vaccines
Purified Protein Vaccines
Live Attenuated Bacterial Vaccines
Killed Bacterial Vaccines
Others
Market Segment by Applications, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Bacterial Vaccines Market Overview
1.1 Product Overview and Scope of Bacterial Vaccines
1.2 Classification of Bacterial Vaccines by Types
1.2.1 Global Bacterial Vaccines Revenue Comparison by Types (2017-2023)
1.2.2 Global Bacterial Vaccines Revenue Market Share by Types in 2017
1.2.3 Capsular Polysaccharide Vaccines
1.2.4 Toxoid Vaccines
1.2.5 Purified Protein Vaccines
1.2.6 Live Attenuated Bacterial Vaccines
1.2.7 Killed Bacterial Vaccines
1.2.8 Others
1.3 Global Bacterial Vaccines Market by Application
1.3.1 Global Bacterial Vaccines Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Bacterial Vaccines Market by Regions
1.4.1 Global Bacterial Vaccines Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Bacterial Vaccines Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Bacterial Vaccines Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Bacterial Vaccines Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Bacterial Vaccines Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Bacterial Vaccines Status and Prospect (2013-2023)
1.5 Global Market Size of Bacterial Vaccines (2013-2023)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Bacterial Vaccines Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Bacterial Vaccines Revenue, Gross Margin and Market Share (2016-2017)
2.2 Merck
2.2.1 Business Overview
2.2.2 Bacterial Vaccines Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Merck Bacterial Vaccines Revenue, Gross Margin and Market Share (2016-2017)
2.3 GlaxoSmithKline
2.3.1 Business Overview
2.3.2 Bacterial Vaccines Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 GlaxoSmithKline Bacterial Vaccines Revenue, Gross Margin and Market Share (2016-2017)
2.4 Sanofi
2.4.1 Business Overview
2.4.2 Bacterial Vaccines Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sanofi Bacterial Vaccines Revenue, Gross Margin and Market Share (2016-2017)
2.5 PaxVax
2.5.1 Business Overview
2.5.2 Bacterial Vaccines Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 PaxVax Bacterial Vaccines Revenue, Gross Margin and Market Share (2016-2017)
2.6 Serum Institute of India
2.6.1 Business Overview
2.6.2 Bacterial Vaccines Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Serum Institute of India Bacterial Vaccines Revenue, Gross Margin and Market Share (2016-2017)
2.7 Emergent BioDefense Operations Lansing
2.7.1 Business Overview
2.7.2 Bacterial Vaccines Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Emergent BioDefense Operations Lansing Bacterial Vaccines Revenue, Gross Margin and Market Share (2016-2017)
3 Global Bacterial Vaccines Market Competition, by Players
3.1 Global Bacterial Vaccines Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Bacterial Vaccines Players Market Share
3.2.2 Top 10 Bacterial Vaccines Players Market Share
3.3 Market Competition Trend
4 Global Bacterial Vaccines Market Size by Regions
4.1 Global Bacterial Vaccines Revenue and Market Share by Regions
4.2 North America Bacterial Vaccines Revenue and Growth Rate (2013-2018)
4.3 Europe Bacterial Vaccines Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Bacterial Vaccines Revenue and Growth Rate (2013-2018)
4.5 South America Bacterial Vaccines Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Bacterial Vaccines Revenue and Growth Rate (2013-2018)
5 North America Bacterial Vaccines Revenue by Countries
5.1 North America Bacterial Vaccines Revenue by Countries (2013-2018)
5.2 USA Bacterial Vaccines Revenue and Growth Rate (2013-2018)
5.3 Canada Bacterial Vaccines Revenue and Growth Rate (2013-2018)
5.4 Mexico Bacterial Vaccines Revenue and Growth Rate (2013-2018)
6 Europe Bacterial Vaccines Revenue by Countries
6.1 Europe Bacterial Vaccines Revenue by Countries (2013-2018)
6.2 Germany Bacterial Vaccines Revenue and Growth Rate (2013-2018)
6.3 UK Bacterial Vaccines Revenue and Growth Rate (2013-2018)
6.4 France Bacterial Vaccines Revenue and Growth Rate (2013-2018)
6.5 Russia Bacterial Vaccines Revenue and Growth Rate (2013-2018)
6.6 Italy Bacterial Vaccines Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Bacterial Vaccines Revenue by Countries
7.1 Asia-Pacific Bacterial Vaccines Revenue by Countries (2013-2018)
7.2 China Bacterial Vaccines Revenue and Growth Rate (2013-2018)
7.3 Japan Bacterial Vaccines Revenue and Growth Rate (2013-2018)
7.4 Korea Bacterial Vaccines Revenue and Growth Rate (2013-2018)
7.5 India Bacterial Vaccines Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Bacterial Vaccines Revenue and Growth Rate (2013-2018)
8 South America Bacterial Vaccines Revenue by Countries
8.1 South America Bacterial Vaccines Revenue by Countries (2013-2018)
8.2 Brazil Bacterial Vaccines Revenue and Growth Rate (2013-2018)
8.3 Argentina Bacterial Vaccines Revenue and Growth Rate (2013-2018)
8.4 Colombia Bacterial Vaccines Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Bacterial Vaccines by Countries
9.1 Middle East and Africa Bacterial Vaccines Revenue by Countries (2013-2018)
9.2 Saudi Arabia Bacterial Vaccines Revenue and Growth Rate (2013-2018)
9.3 UAE Bacterial Vaccines Revenue and Growth Rate (2013-2018)
9.4 Egypt Bacterial Vaccines Revenue and Growth Rate (2013-2018)
9.5 Nigeria Bacterial Vaccines Revenue and Growth Rate (2013-2018)
9.6 South Africa Bacterial Vaccines Revenue and Growth Rate (2013-2018)
10 Global Bacterial Vaccines Market Segment by Type
10.1 Global Bacterial Vaccines Revenue and Market Share by Type (2013-2018)
10.2 Global Bacterial Vaccines Market Forecast by Type (2018-2023)
10.3 Capsular Polysaccharide Vaccines Revenue Growth Rate (2013-2023)
10.4 Toxoid Vaccines Revenue Growth Rate (2013-2023)
10.5 Purified Protein Vaccines Revenue Growth Rate (2013-2023)
10.6 Live Attenuated Bacterial Vaccines Revenue Growth Rate (2013-2023)
10.7 Killed Bacterial Vaccines Revenue Growth Rate (2013-2023)
10.8 Others Revenue Growth Rate (2013-2023)
11 Global Bacterial Vaccines Market Segment by Application
11.1 Global Bacterial Vaccines Revenue Market Share by Application (2013-2018)
11.2 Bacterial Vaccines Market Forecast by Application (2018-2023)
11.3 Hospital Pharmacies Revenue Growth (2013-2018)
11.4 Retail Pharmacies Revenue Growth (2013-2018)
11.5 Online Pharmacies Revenue Growth (2013-2018)
12 Global Bacterial Vaccines Market Size Forecast (2018-2023)
12.1 Global Bacterial Vaccines Market Size Forecast (2018-2023)
12.2 Global Bacterial Vaccines Market Forecast by Regions (2018-2023)
12.3 North America Bacterial Vaccines Revenue Market Forecast (2018-2023)
12.4 Europe Bacterial Vaccines Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Bacterial Vaccines Revenue Market Forecast (2018-2023)
12.6 South America Bacterial Vaccines Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Bacterial Vaccines Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Bacterial Vaccines Picture
Table Product Specifications of Bacterial Vaccines
Table Global Bacterial Vaccines and Revenue (Million USD) Market Split by Product Type
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
